Prosecution Insights
Last updated: August 18, 2026

Examiner: ZEMAN, MARY K

Tech Center 1600 • Art Units: 1631 1642 1672 1681 1686

This examiner grants 59% of resolved cases

Performance Statistics

59.0%
Allow Rate
-1.0% vs TC avg
564
Total Applications
+34.3%
Interview Lift
1456
Avg Prosecution Days
Based on 541 resolved cases, 2023–2026

Rejection Statute Breakdown

31.8%
§101 Eligibility
14.6%
§102 Novelty
12.5%
§103 Obviousness
23.6%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19340724 PLATFORMS, SYSTEMS, AND METHODS FOR MULTI-OBJECTIVE OPTIMIZATION AND COMPARATIVE ANALYSIS FOR SYNTHETIC BIOLOGY DEVELOPMENT Final Rejection X Development LLC
17449734 METHODS AND COMPOSITIONS FOR IMPUTING OR PREDICTING GENOTYPE OR PHENOTYPE Final Rejection PIONEER HI-BRED INTERNATIONAL, INC.
17591355 Systems and Methods for Sequencing T Cell Receptors and Uses Thereof Non-Final OA Regeneron Pharmaceuticals, Inc.
17814042 MOLECULAR LABEL COUNTING ADJUSTMENT METHODS Non-Final OA Becton, Dickinson And Company
18038453 BIOMARKERS FOR DIAGNOSING PROSTATE CANCER, COMBINATION THEREOF, AND USE THEREOF Non-Final OA KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month